A Study to Evaluate the Efficacy and Safety of Dual add-on Therapy With Gemigliptin 50 mg and Dapagliflozin 10 mg Added to Metformin Who Have Inadequate Glycemic Control on Metformin Alone
Clinical trial NCT04255238 · UNKNOWN
Trial details
- NCT number
- NCT04255238
- Sponsor
- LG Chem
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-30
- Primary completion
- 2022-05-30
- Enrollment
- 468
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.